These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32478898)

  • 1. TEG PlateletMapping assay results may be misleading in the presence of cold stored platelets.
    Scorer TG; FitzGibbon L; Aungraheeta R; Sharma U; Peltier GC; McIntosh CS; Reddoch-Cardenas KM; Meyer A; Cap AP; Mumford AD
    Transfusion; 2020 Jun; 60 Suppl 3():S119-S123. PubMed ID: 32478898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative in vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists on platelet-mediated clot strength induced by tissue factor with use of thromboelastography: differentiation among glycoprotein IIb/IIIa antagonists.
    Mousa SA; Khurana S; Forsythe MS
    Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):1162-7. PubMed ID: 10764688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycoprotein IIb/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses.
    Judge HM; Buckland RJ; Holgate CE; Storey RF
    Platelets; 2005 Nov; 16(7):398-407. PubMed ID: 16236601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of thromboelastography in the assessment of platelet function.
    Bowbrick VA; Mikhailidis DP; Stansby G
    Clin Appl Thromb Hemost; 2003 Apr; 9(2):137-42. PubMed ID: 12812383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cold stored platelets in the management of bleeding: is it about bioenergetics?
    George CE; Saunders CV; Morrison A; Scorer T; Jones S; Dempsey NC
    Platelets; 2023 Dec; 34(1):2188969. PubMed ID: 36922733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cold temperatures reduce the sensitivity of stored platelets to disaggregating agents.
    Mondoro TH; Vostal JG
    Platelets; 2002 Feb; 13(1):11-20. PubMed ID: 11918832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FcgammaRII mediates platelet aggregation caused by disintegrins and GPIIb/IIIa monoclonal antibody, AP2.
    Huang TF; Chang CH; Ho PL; Chung CH
    Exp Hematol; 2008 Dec; 36(12):1704-13. PubMed ID: 18809237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Specialized Pro-Resolving Mediators to Alleviate Cold Platelet Storage Lesion.
    Reddoch-Cardenas KM; Sharma U; Salgado CL; Cantu C; Darlington DN; Pidcoke HF; Bynum JA; Cap AP
    Transfusion; 2020 Jun; 60 Suppl 3():S112-S118. PubMed ID: 32478925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro measurement of platelet glycoprotein IIb/IIIa receptor blockade by abciximab: interindividual variation and increased platelet secretion.
    Rossi F; Rossi E; Pareti FI; Colli S; Tremoli E; Gallo L
    Haematologica; 2001 Feb; 86(2):192-8. PubMed ID: 11224490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of platelets aggregation in the process of ductus arteriosus closure of newborn pups].
    Ren Y; Gao X; Zhao D; Wang L; Huang D; Su M
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Nov; 34(11):1194-1199. PubMed ID: 36567565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban.
    Koster A; Kukucka M; Bach F; Meyer O; Fischer T; Mertzlufft F; Loebe M; Hetzer R; Kuppe H
    Anesthesiology; 2001 Feb; 94(2):245-51. PubMed ID: 11176088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic characterization of the interaction between abciximab or tirofiban with unfractionated or a low molecular weight heparin in healthy subjects.
    Klinkhardt U; Graff J; Westrup D; Kirchmaier CM; Esslinger HU; Breddin HK; Harder S
    Br J Clin Pharmacol; 2001 Sep; 52(3):297-305. PubMed ID: 11560562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Ca2+ chelation on the platelet inhibitory ability of the GPIIb/IIIa antagonists abciximab, eptifibatide and tirofiban.
    Marciniak SJ; Jordan RE; Mascelli MA
    Thromb Haemost; 2001 Mar; 85(3):539-43. PubMed ID: 11307828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects Of Glycoprotein IIb/IIIa Antagonists: Anti Platelet Aggregation And Beyond.
    Giordano A; Musumeci G; D'Angelillo A; Rossini R; Zoccai GB; Messina S; Coscioni E; Romano S; Romano MF
    Curr Drug Metab; 2016; 17(2):194-203. PubMed ID: 26652157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
    Gawaz M; Ruf A; Pogatsa-Murray G; Dickfeld T; Rüdiger S; Taubitz W; Fischer J; Müller I; Meier D; Patscheke H; Schömig A
    Thromb Haemost; 2000 Jun; 83(6):915-22. PubMed ID: 10896249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet dysfunction reversal with cold-stored vs room temperature-stored platelet transfusions.
    Kogler VJ; Miles JA; Özpolat T; Bailey SL; Byrne DA; Bawcom-Randall M; Wang Y; Larsen HJ; Reed F; Fu X; Stolla M
    Blood; 2024 May; 143(20):2073-2088. PubMed ID: 38427589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First report of the point-of-care TEG: A technical validation study of the TEG-6S system.
    Gurbel PA; Bliden KP; Tantry US; Monroe AL; Muresan AA; Brunner NE; Lopez-Espina CG; Delmenico PR; Cohen E; Raviv G; Haugen DL; Ereth MH
    Platelets; 2016 Nov; 27(7):642-649. PubMed ID: 27809712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effect of different platelet GPIIb/IIa antagonists on the dynamics of platelet/fibrin-mediated clot strength induced using thromboelastography.
    Mousa SA; Forsythe MS
    Thromb Res; 2001 Oct; 104(1):49-56. PubMed ID: 11583738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using thrombelastography to determine the efficacy of the platelet glycoprotein IIb/IIIa antagonist, roxifiban, on platelet/fibrin-mediated clot dynamics in humans.
    Mousa SA; Bozarth JM; Seiffert D; Feuerstein GZ
    Blood Coagul Fibrinolysis; 2005 Apr; 16(3):165-71. PubMed ID: 15795533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin.
    Reiter RA; Mayr F; Blazicek H; Galehr E; Jilma-Stohlawetz P; Domanovits H; Jilma B
    Blood; 2003 Dec; 102(13):4594-9. PubMed ID: 12920042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.